查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1835397

靜脈輸液袋市場按應用、材料、包裝類型、流量、最終用戶和產品類型分類－全球預測，2025-2032

IV Bags Market by Application, Material, Packaging Type, Flow Rate, End User, Product Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，靜脈輸液袋市場規模將成長至 472.7 億美元，複合年成長率為 7.27%。

主要市場統計數據
基準年2024年 269.5億美元
預計2025年 289.1億美元
預測年份：2032年 472.7億美元
複合年成長率（%） 7.27%

多方面 IV 環境的簡明說明，重點關注臨床使用案例、材料演變和決定供應商和提供者選擇的結構部分

輸液系統仍然是急性和慢性護理的基本組成部分，在各種臨床環境中支援液體治療、藥物管理、營養支持和緊急復甦。近年來，各種壓力不斷增加，靜脈輸液袋設計和輸送的戰略重要性也日益凸顯，包括轉向不使用傳統塑化劑的材料科學、更加重視患者安全和藥物相容性，以及輸送方式從醫療機構擴展到居家照護和門診。這些因素共同迫使製造商和醫療保健提供者重新思考其產品組合、採購方法和臨床工作流程。

相關人員在評估產品選擇時必須考慮市場結構的多個面向。按應用分類，市場涵蓋門診護理、居家照護和醫院，其中醫院環境進一步細分為普通病房、ICU、手術室等。按材料分類，市場主要關注非 PVC 和 PVC 選項，其中 PVC 進一步分為乙烯醋酸乙烯酯和聚烯。按包裝類型分類，設備分為多腔和單腔配置，其中多腔設備進一步分為雙腔和三腔。依流速分類，臨床應用分為大滴灌和微滴灌系統。按最終用戶分類，市場包括門診護理中心、診所、居家照護中心和醫院。按產品類型分類，市場分析包括特殊藥物輸送、標準靜脈輸液和全腸外營養。這個多維框架是以下章節所探討的分析主題的基礎。

確定將影響輸液解決方案設計、製造優先順序和臨床部署策略的材料、監管和護理服務轉型

靜脈輸液袋市場正在經歷一場變革性的轉變，這得益於材料創新、不斷變化的監管環境以及醫療服務模式的轉變，這些因素正在全面重塑產品規格和採購邏輯。由於對塑化劑遷移、藥物相容性和環境永續性的擔憂，聚合物科學的進步正在加速傳統PVC配方替代品的採用。因此，製造商正在投資乙烯醋酸乙烯酯和聚烯的加工能力，以滿足臨床醫生對更安全、化學惰性容器的需求。

同時，醫療保健服務正日益分散化。門診和居家醫療機構正在拓展先前僅限於醫院的醫療服務，因此更加重視能夠簡化非臨床環境下給藥並降低給藥風險的包裝形式。諸如大滴灌和微滴灌裝置等流量匹配解決方案也正在獲得差異化的臨床應用。此外，數位可追溯性和一次性使用管理計畫正在改變生命週期經濟學。總而言之，這些趨勢要求供應商必須根據不斷變化的臨床和商業性參數，調整其研發、製造能力和監管策略。

分析 2025 年關稅造成的累積營運和商業影響以及它們如何影響供應商策略、庫存設計和採購選擇。

2025年實施的關稅及相關貿易措施正在對整個靜脈注射藥品供應鏈的採購成本、供應商選擇和庫存策略產生累積影響。關稅帶來的成本壓力正促使下游買家重新評估其採購區域，並專注於供應商多元化和近岸外包，以緩衝貿易政策波動帶來的風險。採購團隊在重新配置供應商層級時，擴大在到岸成本與供應商可靠性、監管部門的核准和品質認證之間取得平衡。

實際上，製造商和合約包裝商正在調整定價模式，並與原料供應商重新協商契約，以在保持無菌和合規標準的同時保護淨利率。跨境運輸的行政負擔不斷增加，這提升了垂直整合供應商和區域製造地的價值，這些供應商和基地能夠滿足當地需求，同時降低海關手續的複雜性。庫存政策正在轉向一種混合方法，將戰略安全庫存與大批量產品的即時補貨相結合，並輔以增強的可視性工具。整體而言，關稅環境正在加速有利於彈性、可追溯性和靈活生產能力的結構性調整。

詳細的細分分析揭示了應用、材料選擇、包裝結構、流動特性、最終用戶環境和產品類型如何推動差異化的臨床和商業性需求

細分洞察揭示了涵蓋臨床環境、材料、包裝形式、流程配置、最終用戶類型和產品類型的細微變化軌跡，每個軌跡都具有獨特的策略意義。醫院本身對不同用例（例如普通病房、ICU 和手術室）也有不同的需求，這些差異會影響容器的堅固性、相容性規格和標籤檢視清晰度。從 PVC 轉向非 PVC 材料（例如乙烯醋酸乙烯和聚烯）的轉變，是出於對藥物交互作用和環境方面的考慮，這需要對製造流程和驗證通訊協定進行相應的更改。

包裝類型已成為產品差異化的關鍵點。雖然單腔解決方案仍然是標準輸液的核心，但包括雙腔和三腔設計在內的多腔形式在特殊藥物傳輸和照護現場混合療法中越來越受歡迎。大滴和微滴的流速反映了特定的臨床應用，其中大滴針對快速液體復甦進行了最佳化，微滴針對兒科和門診環境中的精準給藥進行了最佳化。最終使用者包括門診護理中心、診所、居家照護中心和醫院，需要量身定做的培訓、標籤和分銷方式。特殊藥物輸送、標準輸液和全腸外營養等產品類型進一步影響了保存期限要求、相容性測試以及對低溫運輸或受控環境包裝的需求。這些細分洞察應指南產品系列的合理化、有針對性的產能投資以及臨床市場准入。

美洲、歐洲、中東和非洲以及亞太地區的動態將如何影響製造選擇、監管導航和臨床採用模式的區域比較

區域動態正在塑造供給側能力和需求模式，每個宏觀區域都展現出不同的法規結構、製造生態系統和臨床應用曲線。在美洲，成熟的臨床基礎設施和強大的採購管道促進了新材料和高利潤特種產品的快速應用，而製造商與大型醫療保健系統的接近性則支持了在合規性和產品測試方面的密切合作。在歐洲、中東和非洲，監管多樣性和報銷差異為能夠駕馭國家醫療保健系統和當地核准途徑的供應商帶來了挑戰和機遇，而區域中心對於分銷和本地生產仍然至關重要。

在亞太地區，生產規模和成本競爭力仍然至關重要，這得益於越來越多的聚合物加工商和契約製造能夠同時供應國內和出口市場。該地區的門診和居家醫療機構的臨床應用也在加速，這推動了對方便用戶使用型和分散式包裝的需求。包括關稅和物流限制在內的區域貿易動態正在推動更本地化的生產力計畫方法，許多公司採用區域製造佈局，以縮短前置作業時間並減少監管摩擦。這些地理區域分類應體現在打入市場策略、監理投資和供應鏈設計。

企業策略洞察，展示製造商和供應商如何利用材料創新、品質系統和夥伴關係模式來獲得臨床和商業性優勢

公司層級的行動體現了一系列通用的策略性應對措施，包括投資材料創新、提升無菌生產能力，以及尋求策略夥伴關係和製造外包協議以加速產能部署。領先的公司正在透過高效的非PVC製劑生產線實現差異化，以解決藥物相容性和安全性問題；而其他公司則正在最佳化PVC製劑配方，以提升其生命週期成本和性能優勢。同時，一些公司正在開發多腔解決方案和專用輸送系統，以佔領更高價值的臨床市場，並滿足臨床醫生對簡化混合和縮短準備時間的需求。

在營運方面，企業優先考慮監管協調、品管體係以及跨製造和分銷管道的數位可追溯性，以滿足買家對透明度和信任度的期望。一些企業也正在探索永續性舉措，例如使用可回收材料、降低滅菌能耗以及盡量減少包裝，作為其採購決策中的差異化因素。這些策略舉措表明，該行業正在平衡漸進式產品演進和有針對性的技術創新，以應對臨床複雜性、監管審查和供應鏈彈性等多重壓力。

為製造商、供應商和採購領導者提供優先、可行的建議，以提高其靜脈輸液產品系列的彈性、創新和市場應對力

產業領導者應採取一系列優先可行的措施，使營運能力與不斷變化的臨床需求和政策環境保持一致。首先，實現供應商多元化，並建立區域性生產緩衝機制，以維持對本地需求的應對力，同時降低跨境政策風險。其次，加快對乙烯醋酸乙烯酯和聚烯等非PVC材料的投資，同時在臨床適用的領域保留可行的PVC選擇，確保產品系列符合各種相容性和永續性標準。

第三，在臨床上重視輸液便利性和藥物穩定性的領域，我們將優先考慮多腔和專用輸送平台，並調整門診和居家照護環境下的包裝和標籤。第四，我們將投資數位可追溯性和庫存最佳化工具，以提高供應視覺性，消除浪費，並實施平衡安全庫存和高效週轉的混合庫存策略。第五，我們將積極與監管機構和大型採購商合作，簡化核准流程，使產品規格與採購要求保持一致。最後，我們將與臨床領導者建立有針對性的夥伴關係關係，以檢驗產品在重症監護室、手術室和家庭環境中的性能，從而縮短產品應用曲線並強化我們的價值提案。

對研究通訊協定進行透明的描述，結合對臨床醫生和供應商的初步調查、技術審查、供應鏈映射和三角二次分析，可以得出可靠的結論

該研究將結構化一手訪談、技術白皮書、監管文件和上市公司披露的證據與供應鏈圖譜和以材料為中心的實驗室評估相結合。一手研究包括與醫院病房、ICU團隊和門診的臨床醫生、採購專業人員、委託製造和聚合物供應商的對話。二級資訊來源提供了法規發展、滅菌通訊協定和設備相容性文獻的背景檢驗，以支援對產品和製造影響的穩健分析。

我們的分析方法強調定性輸入的主題編碼、材料性能特徵的比較評估以及基於情境的關稅和物流中斷評估。我們承認專有製造數據或機密商業條款會限制全面了解情況。在這些情況下，我們透過多個獨立資訊來源證實了我們的研究結果，以確保可靠性。我們的調查方法優先考慮在臨床、監管和供應鏈方面保持平衡的觀點，為商業和臨床相關人員提供決策相關的見解。

將材料轉型、醫療保健服務轉變和貿易動態等核心策略要務整合到市場和產品決策的連貫藍圖中

總而言之，靜脈輸液袋產業正處於策略曲折點，材料科學、供應鏈韌性以及不斷發展的醫療保健環境正在匯聚，重塑產品優先級和商業策略。相關人員必須認知到，向非PVC材料的轉變、多腔和特殊輸液形式日益成長的重要性以及醫療服務向門診和家庭環境的分散化並非孤立的趨勢，而是相互關聯的因素，需要研發、製造和上市等職能部門的綜合應對。

此外，關稅和貿易環境正在加速對採購和庫存策略的反思，那些將本地製造能力與有效的品質系統和強力的監管途徑相結合的公司將獲得豐厚的回報。那些積極主動地將產品系列與臨床工作流程相結合、投資於可追溯性和永續性，並儘早與採購負責人和監管機構接洽的公司，將最有可能將這些結構性變化轉化為競爭優勢。這些摘要見解為準備引領輸液治療解決方案下一階段發展的領導者提供了策略藍圖。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 引入環保、可生物分解的靜脈輸液包裝，以減少對環境的影響
  • 擴大採用整合物聯網靜脈輸液袋的智慧輸液幫浦進行遠端患者監護
  • 在緊急醫療環境中，對具有延長保存期限的預充式預填充袋的需求正在增加
  • 擴大採用床邊條碼掃描系統來即時檢驗靜脈輸液袋藥物的準確性
  • 可依患者個體代謝需求客製化的腸外營養靜脈輸液袋需求激增

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章 靜脈輸液袋市場應用分析

  • 門診治療
  • 居家照護
  • 醫院
    • 普通病房
    • ICU
    • 手術室

9. 靜脈輸液袋市場（依材質）

  • 非PVC
    • 乙烯醋酸乙烯酯
    • 聚烯
  • PVC

第10章 靜脈輸液袋市場（依包裝類型）

  • 多室
    • 雙腔
    • 三腔
  • 單室

第 11 章 靜脈輸液袋市場（依流量）

  • 宏滴
  • 微滴

第12章 靜脈輸液袋市場（依最終用戶）

  • 門診治療中心
  • 診所
  • 居家照護中心
  • 醫院

第13章 靜脈輸液袋市場（依產品類型）

  • 特殊藥品管理
  • 標準IV溶液
  • 全靜脈營養

第14章 輸液袋市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 15 章 靜脈輸液袋市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 IV 袋市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • Terumo Corporation
    • ICU Medical, Inc.
    • Pfizer Inc.
    • Nipro Corporation
    • Grifols, SA
    • Vygon SA
    • Otsuka Pharmaceutical Co., Ltd.
Product Code: MRR-43470FC6083B

The IV Bags Market is projected to grow by USD 47.27 billion at a CAGR of 7.27% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 26.95 billion
Estimated Year [2025] USD 28.91 billion
Forecast Year [2032] USD 47.27 billion
CAGR (%) 7.27%

A concise orientation to the multifaceted intravenous infusion environment highlighting clinical use cases, material evolutions, and the structured segments that define supplier and provider choices

Intravenous infusion systems remain a foundational component of acute and chronic care delivery, supporting fluid therapy, drug administration, nutrition, and emergency resuscitation in diverse clinical environments. Recent years have seen converging pressures that elevate the strategic importance of IV bag design and supply resilience: shifts in material science away from legacy plasticizers, heightened emphasis on patient safety and drug compatibility, and expanding delivery beyond institutional walls into homecare and ambulatory settings. Together, these forces require manufacturers and providers to reassess portfolio composition, procurement practices, and clinical workflows.

As stakeholders evaluate product choices, they must consider multiple dimensions of the market structure. Based on Application, market study accounts for Ambulatory Care, Homecare, and Hospital settings, with Hospital environments further delineated across General Ward, ICU, and Operating Theatre. Based on Material, focus spans Non-PVC and PVC formats, where Non-PVC options are further categorized into Ethylene Vinyl Acetate and Polyolefin. Based on Packaging Type, devices are examined across Multi-Chamber and Single Chamber configurations, with Multi-Chamber split into Dual Chamber and Triple Chamber options. Based on Flow Rate, clinical use differentiates Macrodrip and Microdrip systems. Based on End User, the landscape includes Ambulatory Care Centers, Clinics, Homecare Centers, and Hospitals. Based on Product Type, the market is analyzed across Specialty Drug Delivery, Standard IV Solutions, and Total Parenteral Nutrition. This multidimensional framing establishes a foundation for the deeper analytical themes explored in subsequent sections.

Identification of converging material, regulatory, and care-delivery transformations reshaping intravenous solution design, manufacturing prioritization, and clinical deployment strategies

The IV bags landscape is experiencing transformative shifts driven by material innovation, regulatory evolution, and shifts in care delivery models that collectively reconfigure product specification and procurement logic. Advances in polymer science are accelerating the adoption of alternatives to traditional PVC formulations, driven by concerns about plasticizer migration, drug compatibility, and environmental sustainability. Consequently, manufacturers are investing in Ethylene Vinyl Acetate and Polyolefin processing capabilities to meet clinician demands for safer, more chemically inert containers.

Concurrently, care delivery is decentralizing: ambulatory and homecare settings are playing an expanding role in therapies historically confined to hospitals, which places a premium on packaging formats that simplify administration and reduce risk in non-clinical environments. Multi-chamber systems that enable co-administration and extended stability are becoming more relevant for specialty drug delivery and total parenteral nutrition, while flow-rate tailored solutions such as macrodrip and microdrip devices are seeing differentiated clinical adoption. Moreover, digital traceability and single-use stewardship programs are altering lifecycle economics. Taken together, these trends create an imperative for suppliers to align R&D, manufacturing capacity, and regulatory strategies with shifting clinical and commercial parameters.

Analysis of the cumulative operational and commercial consequences stemming from tariff measures in 2025 and how they are influencing supplier strategy, inventory design, and procurement choices

The imposition of tariffs and related trade measures in 2025 has introduced a cumulative set of effects on procurement costs, supplier selection, and inventory strategies across the intravenous supply chain. Tariff-induced cost pressure has prompted downstream buyers to reassess sourcing geographies, with an emphasis on supplier diversification and nearshoring to buffer exposure to trade policy volatility. Procurement teams are increasingly balancing landed cost with supplier reliability, regulatory approvals, and quality certification when reconfiguring supplier tiers.

In practical terms, manufacturers and contract packagers have adjusted pricing models and renegotiated contracts with raw material suppliers to preserve margin while maintaining sterility and compliance standards. The heavier administrative burden for cross-border shipments has elevated the value of vertically integrated suppliers and regional manufacturing footprints capable of servicing local demand with reduced customs complexity. Inventory policies have shifted toward a hybrid approach that blends strategic safety stocks with just-in-time replenishment for high-turn items, supported by enhanced visibility tools. Overall, the tariff environment has accelerated structural adjustments that favor resilience, traceability, and flexible production capacity.

Detailed segmentation analysis uncovering how application, material choice, packaging architecture, flow characteristics, end-user contexts, and product types drive differentiated clinical and commercial requirements

Segmentation insights reveal nuanced trajectories across clinical settings, materials, packaging formats, flow configurations, end-user types, and product categories, each with distinct strategic implications. Application-wise, demand patterns differ between Ambulatory Care and Homecare versus Hospital environments, and hospitals themselves present differentiated needs across General Ward, ICU, and Operating Theatre use cases; this variation influences container robustness, compatibility specifications, and labeling clarity. Material selection is a critical differentiator: the move from PVC toward Non-PVC options such as Ethylene Vinyl Acetate and Polyolefin is motivated by drug interaction concerns and environmental considerations, and it necessitates corresponding changes in manufacturing processes and validation protocols.

Packaging type has emerged as a key point of product differentiation, with Single Chamber solutions remaining core for standard IV fluids while Multi-Chamber formats, including Dual Chamber and Triple Chamber designs, are gaining prominence in specialty drug delivery and therapies requiring admixture at the point of care. Flow rate segmentation between Macrodrip and Microdrip reflects clinical application specificity, with macrodrip favored for rapid fluid resuscitation and microdrip optimized for precise pediatric or ambulatory administration. End users span Ambulatory Care Centers, Clinics, Homecare Centers, and Hospitals, and each requires tailored training, labeling, and distribution approaches. Product-type distinctions among Specialty Drug Delivery, Standard IV Solutions, and Total Parenteral Nutrition further influence shelf-life requirements, compatibility testing, and cold-chain or controlled-environment packaging needs. These segmentation insights should guide product portfolio rationalization, investment in targeted manufacturing capabilities, and clinical market engagement.

Comparative regional perspectives explaining how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence manufacturing choices, regulatory navigation, and clinical adoption patterns

Regional dynamics are shaping both supply-side capacity and demand patterns, with each macro-region presenting distinct regulatory frameworks, manufacturing ecosystems, and clinical adoption curves. In the Americas, established clinical infrastructures and robust purchasing channels facilitate rapid adoption of new materials and higher-margin specialty products, while proximity between manufacturers and large healthcare systems supports close collaboration on compatibility testing and product trials. Across Europe, Middle East & Africa, regulatory heterogeneity and reimbursement variability create both challenges and opportunities for suppliers able to navigate national health systems and local certification pathways, and regional hubs continue to be important for distribution and localized manufacturing.

In the Asia-Pacific region, production scale and cost competitiveness remain central, supported by a growing number of polymer processors and contract manufacturers capable of supplying both domestic and export markets. The region also shows accelerating clinical adoption in ambulatory and homecare settings, which increases demand for packaging that is user-friendly and compatible with decentralized administration. Cross-region trade dynamics, including tariff considerations and logistics constraints, have encouraged a more localized approach to capacity planning, with many companies adopting regional manufacturing footprints to reduce lead times and regulatory friction. These geographic distinctions should inform market entry strategies, regulatory investment, and supply-chain design.

Insights into corporate strategies showing how manufacturers and suppliers are adopting material innovation, quality systems, and partnership models to capture clinical and commercial advantage

Company-level behavior reveals a set of common strategic responses: investments in material innovation, scaling of sterile manufacturing capacity, and pursuit of strategic partnerships or contract manufacturing agreements to accelerate capability deployment. Leading firms are differentiating through validated Non-PVC product lines that address drug compatibility and safety concerns, while others are optimizing PVC formulations where lifecycle cost and performance remain favorable. In parallel, a subset of companies is developing multi-chamber solutions and specialty delivery systems to capture higher-value clinical segments and to align with clinician needs for simplified admixture and reduced preparation time.

Operationally, firms are prioritizing regulatory harmonization, quality management systems, and digital traceability across manufacturing and distribution channels to meet buyer expectations for transparency and reliability. Several companies are also exploring sustainability initiatives, such as recyclable materials, reduced energy consumption in sterilization, and packaging minimization, as differentiators in procurement decisions. These strategic moves illustrate an industry balancing incremental product evolution with targeted innovation to address the combined pressures of clinical complexity, regulatory scrutiny, and supply-chain resiliency.

A concise set of prioritized, actionable recommendations for manufacturers, suppliers, and procurement leaders to enhance resilience, innovation, and market responsiveness in intravenous product portfolios

Industry leaders should adopt a set of prioritized, actionable steps that align operational capability with evolving clinical requirements and policy landscapes. First, diversify supplier bases and create regional manufacturing buffers to mitigate cross-border policy risk while preserving responsiveness to local demand; this will reduce disruption from tariff shifts and logistics volatility. Second, accelerate investment in Non-PVC materials such as Ethylene Vinyl Acetate and Polyolefin while maintaining validated PVC options where clinically appropriate, ensuring that product portfolios meet a spectrum of compatibility and sustainability criteria.

Third, prioritize multi-chamber and specialty delivery platforms for segments where admixture convenience and drug stability command clinical preference, and tailor packaging and labeling for ambulatory and homecare environments. Fourth, invest in digital traceability and inventory optimization tools to improve supply visibility and reduce waste, enabling hybrid inventory strategies that balance safety stocks with efficient turnover. Fifth, engage proactively with regulators and large purchasers to streamline approvals and align product specifications with procurement requirements. Finally, pursue targeted partnerships with clinical leaders to validate product performance in ICU, Operating Theatre, and home settings, thereby shortening adoption curves and strengthening value propositions.

A transparent explanation of research protocols combining primary clinician and supplier interviews with technical review, supply-chain mapping, and triangulated secondary analysis to support robust conclusions

This research synthesized evidence from structured primary interviews, technical white papers, regulatory filings, and public company disclosures, triangulated with supply-chain mapping and material-focused laboratory assessments. Primary research included conversations with clinicians across hospital wards, ICU teams, and ambulatory care practitioners, as well as procurement specialists, contract manufacturers, and polymer suppliers. Secondary sources provided contextual validation on regulatory trends, sterilization protocols, and device compatibility literature, supporting a robust analysis of product and manufacturing implications.

Analytical methods emphasized thematic coding of qualitative inputs, comparative assessment of material performance characteristics, and scenario-based evaluation of tariff and logistics disruptions. Limitations are acknowledged where proprietary manufacturing data or confidential commercial terms constrains full visibility; in these instances, findings were corroborated through multiple independent sources to ensure reliability. The methodology prioritizes a balanced view across clinical, regulatory, and supply-chain dimensions to furnish decision-relevant insights for commercial and clinical stakeholders.

Synthesis of core strategic imperatives that tie material transitions, care delivery shifts, and trade dynamics into a cohesive roadmap for market and product decisions

In conclusion, the IV bags sector is at a strategic inflection point where material science, supply-chain resilience, and evolving care settings converge to reshape product priorities and commercial strategies. Stakeholders must recognize that the shift toward Non-PVC materials, the growing relevance of multi-chamber and specialty delivery formats, and the decentralization of care into ambulatory and home settings are not isolated trends but interconnected drivers that together demand integrated responses across R&D, manufacturing, and market access functions.

Moreover, the tariff and trade environment has accelerated a rethinking of sourcing and inventory strategies, rewarding firms that combine regional capacity with validated quality systems and strong regulatory pathways. Companies that proactively align product portfolios with clinical workflows, invest in traceability and sustainability, and engage early with purchasers and regulators will be best positioned to convert these structural shifts into competitive advantage. The summary insights presented here offer a strategic roadmap for leaders preparing to navigate the next phase of evolution in intravenous therapy solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Implementation of eco-friendly biodegradable materials in intravenous fluid packaging to reduce environmental impact
  • 5.2. Rising adoption of smart infusion pumps integrated with IoT-enabled intravenous bags for remote patient monitoring
  • 5.3. Increasing demand for prefilled intravenous solution bags with extended shelf life in emergency care settings
  • 5.4. Growing adoption of bedside barcode scanning systems for real-time verification of IV bag medication accuracy
  • 5.5. Surge in demand for customizable parenteral nutrition IV bags tailored to individual patient metabolic requirements

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. IV Bags Market, by Application

  • 8.1. Ambulatory Care
  • 8.2. Homecare
  • 8.3. Hospital
    • 8.3.1. General Ward
    • 8.3.2. ICU
    • 8.3.3. Operating Theatre

9. IV Bags Market, by Material

  • 9.1. Non-PVC
    • 9.1.1. Ethylene Vinyl Acetate
    • 9.1.2. Polyolefin
  • 9.2. PVC

10. IV Bags Market, by Packaging Type

  • 10.1. Multi-Chamber
    • 10.1.1. Dual Chamber
    • 10.1.2. Triple Chamber
  • 10.2. Single Chamber

11. IV Bags Market, by Flow Rate

  • 11.1. Macrodrip
  • 11.2. Microdrip

12. IV Bags Market, by End User

  • 12.1. Ambulatory Care Centers
  • 12.2. Clinics
  • 12.3. Homecare Centers
  • 12.4. Hospitals

13. IV Bags Market, by Product Type

  • 13.1. Specialty Drug Delivery
  • 13.2. Standard IV Solutions
  • 13.3. Total Parenteral Nutrition

14. IV Bags Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. IV Bags Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. IV Bags Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Baxter International Inc.
    • 17.3.2. B. Braun Melsungen AG
    • 17.3.3. Fresenius Kabi AG
    • 17.3.4. Terumo Corporation
    • 17.3.5. ICU Medical, Inc.
    • 17.3.6. Pfizer Inc.
    • 17.3.7. Nipro Corporation
    • 17.3.8. Grifols, S.A.
    • 17.3.9. Vygon SA
    • 17.3.10. Otsuka Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IV BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IV BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IV BAGS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IV BAGS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IV BAGS MARKET SIZE, BY FLOW RATE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IV BAGS MARKET SIZE, BY FLOW RATE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IV BAGS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL IV BAGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL IV BAGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS IV BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL IV BAGS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. IV BAGS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. IV BAGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IV BAGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IV BAGS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IV BAGS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IV BAGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IV BAGS MARKET SIZE, BY GENERAL WARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IV BAGS MARKET SIZE, BY ICU, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IV BAGS MARKET SIZE, BY OPERATING THEATRE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IV BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IV BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IV BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IV BAGS MARKET SIZE, BY MULTI-CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IV BAGS MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IV BAGS MARKET SIZE, BY TRIPLE CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IV BAGS MARKET SIZE, BY MACRODRIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL IV BAGS MARKET SIZE, BY MICRODRIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL IV BAGS MARKET SIZE, BY HOMECARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL IV BAGS MARKET SIZE, BY SPECIALTY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL IV BAGS MARKET SIZE, BY STANDARD IV SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL IV BAGS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL IV BAGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL IV BAGS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS IV BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS IV BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. ASIA-PACIFIC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. ASIA-PACIFIC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. GLOBAL IV BAGS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 324. GLOBAL IV BAGS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 325. ASEAN IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. ASEAN IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. ASEAN IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. ASEAN IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. ASEAN IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 330. ASEAN IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 331. ASEAN IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 332. ASEAN IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 333. ASEAN IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 334. ASEAN IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 335. ASEAN IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. ASEAN IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. ASEAN IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 338. ASEAN IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 339. ASEAN IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 340. ASEAN IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 341. ASEAN IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. ASEAN IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 343. ASEAN IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 344. ASEAN IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 345. GCC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 346. GCC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 347. GCC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 348. GCC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 349. GCC IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 350. GCC IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 351. GCC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 352. GCC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 353. GCC IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 354. GCC IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 355. GCC IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 356. GCC IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 357. GCC IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 358. GCC IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 359. GCC IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 360. GCC IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 361. GCC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 362. GCC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 363. GCC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 364. GCC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 365. EUROPEAN UNION IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 366. EUROPEAN UNION IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 367. EUROPEAN UNION IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 368. EUROPEAN UNION IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 369. EUROPEAN UNION IV BAGS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 370. EUROPEAN UNION IV BAGS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 371. EUROPEAN UNION IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 372. EUROPEAN UNION IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 373. EUROPEAN UNION IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
  • TABLE 374. EUROPEAN UNION IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
  • TABLE 375. EUROPEAN UNION IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 376. EUROPEAN UNION IV BAGS MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 377. EUROPEAN UNION IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 378. EUROPEAN UNION IV BAGS MARKET SIZE, BY MULTI-CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 379. EUROPEAN UNION IV BAGS MARKET SIZE, BY FLOW RATE, 2018-2024 (USD MILLION)
  • TABLE 380. EUROPEAN UNION IV BAGS MARKET SIZE, BY FLOW RATE, 2025-2032 (USD MILLION)
  • TABLE 381. EUROPEAN UNION IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 382. EUROPEAN UNION IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 383. EUROPEAN UNION IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 384. EUROPEAN UNION IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 385. BRICS IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION